Notice of Intent to Sole Source- Georgia Drug and Narcotics Agency (GDNA)

The Food and Drug Administration (FDA) intends to award a sole source contract to the Georgia Drug and Narcotics Agency (GDNA) for investigative services. This requirement falls under NAICS 922120 Police Protection and PSC R499 Support- Professional: Other. The acquisition is conducted under the authority of 10 U.S.C. 2304(c)(5) as authorized by statute. The anticipated period of performance is twelve months from the date of contract award, with all work to be performed in Atlanta, Georgia.

This special notice, issued under solicitation number FDA-RFQ-26-133519, does not have an assigned set-aside. While this is not a request for competitive proposals, the government will consider capability statements from interested parties to determine if a competitive procurement is warranted. One attachment, a PDF titled Notice of Intent_GA.pdf, was published with the notice on March 31, 2026.

Responses must be submitted via email to Nina Montgomery by the deadline of April 3, 2026, at 10:00 AM Eastern Standard Time. The FDA will maintain sole discretion in determining whether to compete the proposed contract action based on the information received. The government will not provide reimbursement for any costs associated with responding to this notice.